Aerobic, Strength, Kegel (ASK) Exercise Intervention Perceptions for Postpartum Health (NCT07790289)
🩺 Plain-English Summary (8th-Grade Level)
The goal of this pilot clinical trial is to learn whether a 12-week home-based exercise programme is feasible, acceptable, and safe for postpartum women in Hong Kong who had hypertensive disorders of pregnancy. The exercise programme is called the Aerobic, Strength, and Kegel exercise programme, or ASK programme. The main questions this study aims to answer are: * Can postpartum women follow the ASK exercise programme at home? * Is the ASK exercise programme acceptable and safe? * Does the ASK exercise programme show early benefits for postpartum recovery and health? Researchers will compare women who receive the ASK exercise programme with women who receive standard postnatal care. Participants will be randomly assigned to one of the two groups. They will complete study assessments at the beginning of the study and after 12 weeks. Women in the ASK exercise programme group will complete three 60-minute exercise sessions per week for 12 weeks, supported by a mobile app and wearable device. Women in the standard postnatal care group will continue to receive usual postnatal care.
Who can join: To join this study, participants generally need to meet the listed inclusion criteria (8 items) and avoid the listed exclusions (8 items).
Location: The Department of Obstetrics and Gynaecology, The Chinese University Of Hong Kong — Hong Kong, Hong Kong
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistCheck every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).
Usually NOT eligible if any of the following apply:
- Multiple pregnancy
- Severe postpartum medical complications or conditions contraindicating exercise participation
- Severe cardiovascular, respiratory, neurological, or major musculoskeletal conditions that may limit safe participation in exercise
- Current use of medication likely to substantially affect cardiac function, including heart failure therapy
- Antibiotic treatment within the preceding month
- Severe mental illness or other condition affecting the ability to provide informed consent or comply with study procedures
- Any medical, obstetric, or psychological condition judged by the research team or attending clinician to make participation unsafe or inappropriate
- Inability or unwillingness to adhere to the 12-week ASK programme or study assessments
🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.
📍 All Participating Trial Locations (1 Sites)
- The Department of Obstetrics and Gynaecology, The Chinese University Of Hong Kong — Hong Kong, Hong Kong
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.